Surrozen, Inc. (SRZN) Insider Trading Activity

NASDAQ$31.18+1.06 (3.52%)
Market Cap
$225.22M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
31 of 849
Rank in Industry
25 of 491

SRZN Insider Trading Activity

SRZN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$16,849,764
28
82
Sells
$7,231,031
6
18

Related Transactions

COLUMN GROUP III GP, LP10 percent owner
9
$5.98M
0
$0
$5.98M
Kutzkey Tim
9
$5.98M
0
$0
$5.98M
TCG Crossover GP II, LLC10 percent owner
10
$4.88M
1
$6.91M
$-2.03M
Li YangExec. Vice President, Research
0
$0
2
$75,008
$-75,008
Williams Charles OChief Operating Officer
0
$0
2
$98,974
$-98,974
Parker Craig CChief Executive Officer
0
$0
1
$150,798
$-150,798

About Surrozen, Inc.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular …

Insider Activity of Surrozen, Inc.

Over the last 12 months, insiders at Surrozen, Inc. have bought $16.85M and sold $7.23M worth of Surrozen, Inc. stock.

On average, over the past 5 years, insiders at Surrozen, Inc. have bought $17.63M and sold $3.63M worth of stock each year.

Highest buying activity among insiders over the last 12 months: COLUMN GROUP III GP, LP (10 percent owner) — $5.98M. Kutzkey Tim () — $5.98M. TCG Crossover GP II, LLC (10 percent owner) — $4.88M.

The last purchase of 106,658 shares for transaction amount of $2.63M was made by TCG Crossover GP II, LLC (10 percent owner) on 2026‑03‑24.

List of Insider Buy and Sell Transactions, Surrozen, Inc.

2026-07-22SaleTCG Crossover GP II, LLC10 percent owner
325,000
4.2524%
$21.25
$6.91M
+9.48%
2026-05-04SaleLi YangExec. Vice President, Research
1,584
0.022%
$33.33
$52,799
-25.26%
2026-05-04SaleWilliams Charles OChief Operating Officer
2,036
0.0283%
$33.33
$67,866
-25.26%
2026-05-04SaleParker Craig CChief Executive Officer
4,524
0.0629%
$33.33
$150,798
-25.26%
2026-03-24PurchaseTCG Crossover GP II, LLC10 percent owner
106,658
1.2291%
$24.69
$2.63M
-0.32%
2026-03-23PurchaseTCG Crossover GP II, LLC10 percent owner
15,223
0.1752%
$24.90
$379,051
-1.11%
2026-03-16PurchaseTCG Crossover GP II, LLC10 percent owner
1,190
0.0136%
$24.99
$29,733
-1.69%
2026-03-13PurchaseTCG Crossover GP II, LLC10 percent owner
35,433
0.4079%
$24.88
$881,463
-0.52%
2026-03-12PurchaseTCG Crossover GP II, LLC10 percent owner
12,374
0.1393%
$24.99
$309,166
-3.13%
2026-02-12PurchaseTCG Crossover GP II, LLC10 percent owner
1,093
0.0122%
$23.86
$26,082
+1.73%
2026-02-11PurchaseTCG Crossover GP II, LLC10 percent owner
17,763
0.1986%
$23.57
$418,763
+2.60%
2026-02-03PurchaseTCG Crossover GP II, LLC10 percent owner
4,355
0.0483%
$21.94
$95,549
+8.97%
2026-02-02PurchaseTCG Crossover GP II, LLC10 percent owner
731
0.0081%
$21.38
$15,629
+13.79%
2026-01-30PurchaseTCG Crossover GP II, LLC10 percent owner
4,271
0.0495%
$21.39
$91,357
+16.68%
2026-01-20PurchaseKutzkey Tim
18,052
0.2296%
$19.60
$353,817
+39.43%
2026-01-20PurchaseCOLUMN GROUP III GP, LP10 percent owner
18,052
0.2296%
$19.60
$353,817
+39.43%
2026-01-16PurchaseKutzkey Tim
2,562
0.0299%
$20.00
$51,240
+25.30%
2026-01-16PurchaseCOLUMN GROUP III GP, LP10 percent owner
2,562
0.0299%
$20.00
$51,240
+25.30%
2026-01-15PurchaseKutzkey Tim
11,893
0.138%
$19.89
$236,540
+25.25%
2026-01-15PurchaseCOLUMN GROUP III GP, LP10 percent owner
11,893
0.138%
$19.89
$236,540
+25.25%
Total: 54
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Kutzkey Tim
1016658
13.5964%
$30.62M100
<0.0001%
COLUMN GROUP III GP, LP10 percent owner
1016658
13.5964%
$30.62M110
+3.03%
TCG Crossover GP II, LLC10 percent owner
574047
7.6771%
$17.29M101
Williams Charles OChief Operating Officer
16571
0.2216%
$499,118.5213
<0.0001%
Parker Craig CChief Executive Officer
16553
0.2214%
$498,576.3611
<0.0001%
Consonance Capman GP, LLCdirector
500000
6.6868%
$15.06M10
BLUTT MITCHELL J MDdirector
434000
5.8041%
$13.07M21
Consonance Life Sciencesdirector
434000
5.8041%
$13.07M21
Livingston Kevin HaroldChief Financial Officer
434000
5.8041%
$13.07M21
Soffer Bennydirector
434000
5.8041%
$13.07M21
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$22,710,871
107
8.53%
$220.62M
$6,146,922
96
-4.70%
$233.68M
$19,239,249
50
-2.24%
$238.33M
$168,352,523
35
13.58%
$218.79M
$295,092,700
21
-0.27%
$237.78M

SRZN Institutional Investors: Active Positions

Increased Positions43+153.57%4M+59.95%
Decreased Positions9-32.14%1M-18.48%
New Positions25New2MNew
Sold Out Positions7Sold Out944,382Sold Out
Total Postitions62+121.43%9M+41.47%

SRZN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Column Group Llc$32,320.0016.66%1.5M00%2025-09-30
Stempoint Capital Lp$15,375.007.93%713,463+26,924+3.92%2025-09-30
Vr Adviser, Llc$13,640.007.03%632,93100%2025-09-30
Ra Capital Management, L.P.$12,987.006.7%602,62600%2025-09-30
5Am Venture Management, Llc$6,681.003.44%310,00000%2025-09-30
Vanguard Group Inc$5,741.002.96%266,418+47,468+21.68%2025-09-30
Vivo Capital, Llc$5,603.002.89%260,00000%2025-09-30
Stonepine Capital Management, Llc$5,391.002.78%250,146-55,883-18.26%2025-09-30
Samsara Biocapital, Llc$5,202.002.68%241,40000%2025-09-30
Nantahala Capital Management, Llc$4,946.002.55%229,52700%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.